Derek Archila

could walk us through kind of the decision framework, you know, what sort of data thresholds may trigger an opt-in

is the expectation we should see deepening responses in these MF cohorts at the update

how much revenue contribution from RUX XR are you really baking into the Jakafi guide

will these be with IV or with the on-body pump from enFuse? And then just a quick follow-up